Biocryst Pharmaceuticals (BCRX) Invested Capital (2016 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Invested Capital came in at $2.4 million in Q1 2026, down 41.4% YoY from $4.1 million in Q1 2025, and down 12.53% on a QoQ basis from $2.8 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Invested Capital (2016 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 10 years of Invested Capital data on file, last reported at $2.4 million in Q1 2026.
- Quarterly Invested Capital fell 41.4% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (down 23.98% YoY) and the FY2025 annual result came in at $2.8 million, down 30.46% from the prior year.
- Invested Capital slipped to $2.4 million in Q1 2026, from $2.8 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $4.4 million in Q4 2023 to a low of $2.4 million in Q1 2026.
- A 5-year average of $3.5 million and a median of $3.8 million in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2023 — Invested Capital soared 68.63% — and 2026, when it slumped 41.4%.
- Tracing BCRX's Invested Capital over 5 years: stood at $2.6 million in 2022, then surged by 68.63% to $4.4 million in 2023, then dropped by 10.73% to $4.0 million in 2024, then plunged by 30.46% to $2.8 million in 2025, then dropped by 12.53% to $2.4 million in 2026.
- The last three Invested Capital figures came in at $2.4 million (Q1 2026), $2.8 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.66 Mn |
| Mar 31, 2025 | 4.11 Mn |
| Dec 31, 2024 | 3.96 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | 4.15 Mn |
| Dec 31, 2023 | 4.44 Mn |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2020 | 19.15 Mn |
| Mar 31, 2020 | 14.03 Mn |
| Dec 31, 2019 | 9.02 Mn |
| Sep 30, 2019 | 4.04 Mn |
| Dec 31, 2018 | 4.58 Mn |
| Sep 30, 2018 | 1.62 Mn |
| Jun 30, 2018 | 6.53 Mn |
| Mar 31, 2018 | 6.50 Mn |